查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888599

全球心包膜疾病市场：市场规模、份额和趋势分析（按药物类别、疾病类型、分销管道和地区划分），细分市场预测（2025-2033 年）

Pericardium Diseases Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Colchicine), By Disease Type (Acute Pericarditis, Recurrent Pericarditis), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

心包膜疾病市场概览

2024年全球心包膜疾病市场规模估计为29.6亿美元，预计2033年将达50.6亿美元。

预计从 2025 年到 2033 年，该行业将以 6.14% 的复合年增长率成长。这一增长是由心血管疾病盛行率的增加、人口老化以及诊断能力的提高所驱动的，这些因素推动了对心包膜疾病（如心膜炎、心包储存和限制性心膜炎）有效治疗的需求。

人们对心臟疾病早期检测和治疗意识的提高，推动了先进治疗方法和微创手术的普及。此外，久坐的生活方式、慢性感染疾病、自体免疫疾病和术后併发症等因素也加剧了疾病负担。

全球心膜炎市场的发展主要得益于医疗实践的进步、生活方式的改变以及技术的创新。心膜炎以心包腔发炎为特征，仍是影响心包膜的最常见疾病。根据美国国家医学图书馆统计，心包膜炎病例分为急性、原发性、亚急性、慢性和復发性五种类型，约占所有病例的15%至30%。高血压、自体免疫疾病、感染疾病以及心肌梗塞併发症等心血管危险因子的日益普遍，正在扩大市场机会。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 心包膜疾病市场：影响因素、趋势与范围

  • 市场关联性展望
  • 市场动态
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTLE分析
    • 管道分析

第四章 全球心包膜疾病市场：依药物类别分類的估算与趋势分析

  • 按药物类别分類的市场份额（2024 年和 2033 年）
  • 按药物类别分類的市场规模预测和趋势分析（2021-2033 年）
  • 非类固醇消炎剂（NSAIDs）
  • 秋水仙碱
  • IL-1β抑制剂
  • 皮质类固醇
  • 免疫抑制剂
  • 其他的

第五章 全球心包膜疾病市场：依疾病类型分類的商业分析

  • 按疾病类型分類的市场份额（2024 年和 2033 年）
  • 按疾病类型分類的市场规模预测和趋势分析（2021-2033 年）
  • 復发性心膜炎
  • 急性心膜炎
  • 限制性心膜炎

第六章 全球心包膜疾病市场：按通路分類的业务分析

  • 按分销管道分類的市场份额（2024 年和 2033 年）
  • 按分销管道分類的市场规模预测和趋势分析（2021-2033）
  • 医院药房
  • 零售药房
  • 网路药房

第七章 全球心包膜疾病市场：按地区分類的商业分析

  • 按地区分類的市场份额分析（2024 年和 2033 年）
  • 市场概览：按地区
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 阿拉伯联合大公国（阿联酋）
Product Code: GVR-4-68040-790-6

Pericardium Diseases Market Summary

The global pericardium diseases market size was estimated at USD 2.96 billion in 2024 and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 6.14% from 2025 to 2033. The growth is driven by the prevalence of cardiovascular conditions, aging populations, and improved diagnostic capabilities, which are driving demand for effective treatments targeting pericardial disorders such as pericarditis, pericardial effusion, and constrictive pericarditis.

Rising awareness about early detection and management of heart-related conditions is boosting the adoption of advanced therapeutics and minimally invasive interventions. Factors such as sedentary lifestyles, chronic infections, autoimmune diseases, and post-surgical complications have also contributed to the growing disease burden.

The global pericarditis market is driven by advancements in healthcare practices, evolving lifestyles, and technological innovation. Pericarditis, characterized by inflammation of the pericardial sac, remains the most prevalent pathological condition affecting the pericardium. According to the National Library of Medicine, pericardial cases are classified into acute, incipient, subacute, chronic, and recurrent forms, accounting for an estimated 15%-30% of cases. The increasing prevalence of cardiovascular risk factors, including hypertension, autoimmune disorders, infections, and post-myocardial infarction complications, is augmenting the market opportunity.

Global Pericardium Diseases Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pericardium diseases market report based on drug class, disease type, distribution channel, and region.

  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Colchicine
  • IL-1B Inhibitors
  • Corticosteroids
  • Immunosuppressant's
  • Others
  • Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Recurrent Pericarditis
  • Acute Pericarditis
  • Constrictive Pericarditis
  • Distribution Channel Outlook (revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Sweden
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Argentina
    • Brazil
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Disease Type
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Global Pericardium Diseases Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Global Pericardium Diseases Market: Drug Class Estimates & Trend Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 4.4.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Colchicine
    • 4.5.1. Colchicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. IL-1B Inhibitors
    • 4.6.1. IL-1B Inhibitors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Corticosteroids
    • 4.7.1. Corticosteroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Immunosuppressants
    • 4.8.1. Immunosuppressants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Global Pericardium Diseases Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2033
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Million)
  • 5.4. Recurrent Pericarditis
    • 5.4.1. Recurrent Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Acute Pericarditis
    • 5.5.1. Acute Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Constrictive Pericarditis
    • 5.6.1. Constrictive Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Pericardium Diseases Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Global Pericardium Diseases Market: Regional Business Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.4. North America
    • 7.4.1. North America Pericardium Diseases Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory framework/ reimbursement structure
      • 7.5.9.3. Competitive Scenario
      • 7.5.9.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. India
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. Japan
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.8. Thailand
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. UAE
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 4 Global Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 5 Global Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 Global Pericardium Diseases Market, by region, 2021-2033 (USD Million)
  • Table 7 North America Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 8 North America Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 9 North America Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 US Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 11 US Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 12 US Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Canada Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 14 Canada Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 15 Canada Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 16 Mexico Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 17 Mexico Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19 Europe Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 20 Europe Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 21 Europe Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 UK Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 23 UK Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 24 UK Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 25 Germany Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 26 Germany Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 27 Germany Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 France Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 29 France Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 30 France Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 31 Italy Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 32 Italy Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 33 Italy Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Spain Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 35 Spain Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 36 Spain Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Norway Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 38 Norway Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 39 Norway Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40 Sweden Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 41 Sweden Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Denmark Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 44 Denmark Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 45 Denmark Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49 Japan Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 50 Japan Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 51 Japan Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 China Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 53 China Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 54 China Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 55 India Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 56 India Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 57 India Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58 Australia Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 59 Australia Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 60 Australia Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Thailand Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 62 Thailand Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 63 Thailand Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 64 South Korea Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 65 South Korea Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 66 South Korea Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 67 Latin America Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 68 Latin America Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 69 Latin America Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70 Brazil Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 71 Brazil Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 72 Brazil Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 Argentina Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 74 Argentina Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 75 Argentina Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 79 South Africa Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 80 South Africa Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 81 South Africa Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Kuwait Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 86 Kuwait Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 87 Kuwait Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 88 UAE Pericardium Diseases Market, by drug class, 2021 - 2033 (USD Million)
  • Table 89 UAE Pericardium Diseases Market, by disease type, 2021 - 2033 (USD Million)
  • Table 90 UAE Pericardium Diseases Market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Global Pericardium Diseases Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Therapeutic Approach and Disease Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Pericardium Diseases Market Dynamics
  • Fig. 12 Pericardium Diseases Market Porter's Five Forces Analysis
  • Fig. 13 Pericardium Diseases Market PESTLE Analysis
  • Fig. 14 Drug Class Market, 2021 - 2033 (USD Million)
  • Fig. 15 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Colchicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 IL-1B Inhibitors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Corticosteroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Immunosuppressants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Disease Type Market, 2021 - 2033 (USD Million)
  • Fig. 22 Recurrent Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Acute Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Constrictive Pericarditis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Distribution Channel Market, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Retail Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Online Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Country Dynamics
  • Fig. 32 U.S. Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Canada Country Dynamics
  • Fig. 34 Canada Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico Country Dynamics
  • Fig. 36 Mexico Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 UK Country Dynamics
  • Fig. 39 UK Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany Country Dynamics
  • Fig. 41 Germany Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Spain Country Dynamics
  • Fig. 47 Spain Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Norway Country Dynamics
  • Fig. 49 Norway Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden Country Dynamics
  • Fig. 51 Sweden Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Denmark Country Dynamics
  • Fig. 53 Denmark Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Japan Country Dynamics
  • Fig. 56 Japan Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 China Country Dynamics
  • Fig. 58 China Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 India Country Dynamics
  • Fig. 60 India Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand Country Dynamics
  • Fig. 64 Thailand Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 South Korea Country Dynamics
  • Fig. 66 South Korea Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Argentina Country Dynamics
  • Fig. 69 Argentina Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Brazil Country Dynamics
  • Fig. 71 Brazil Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Middle East & Africa Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Saudi Arabia Country Dynamics
  • Fig. 74 Saudi Arabia Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 South Africa Country Dynamics
  • Fig. 76 South Africa Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Kuwait Country Dynamics
  • Fig. 78 Kuwait Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 UAE Country Dynamics
  • Fig. 80 UAE Pericardium Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)